18 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... in HIV-AIDS Preventing ... Prophylaxis) Indication ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Recommendations for Preventing ... Clinical Disease Indication ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General ... Management Considerations ... #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS Indications ... CD4 count <100 cells ... opportunistic #infections ... #HIVAIDS #management
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... 12 000 or <400 cells ... approved for this indication ... #SSTIs #Algorithm
Acute Diarrhea - Differential Diagnosis Framework
1)  Diagnostic studies only for dysentery, severe disease, >7 days
2)
recommended Infectious ... , Cystisospora belli ... : Medications, Acute ... NonInfectious #Algorithm ... #gastroenterology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... -6 activates T cells ... respiratory tract infection ... #Pharmacology #Management ... #Medications
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
in HIV-AIDS Preventing ... CD4 count >100 cells ... ., concomitant medications ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis Indication ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Histoplasma Capsulatum Infections ... in HIV-AIDS Indications ... #Treatment #management ... #HIVAIDS #pharmacology